Eczema Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older, of any gender.
- People for whom a doctor has already decided, separately from and before this study, to prescribe Stapokibart Injection for atopic dermatitis (a type of eczema), based on the prescribing guidelines used in China.
Who may not be able to join:
- People who have had a known allergic reaction to Stapokibart Injection in the past.
- People who are currently taking part in, or planning to take part in, another clinical trial that involves a medical treatment or intervention.
- People who have a blood cancer or a cancer affecting the blood and bone marrow.
- People who are pregnant.
- People who have any other condition that, in the opinion of the trial doctor, may affect their ability to take part in the study (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 028-88610620
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The incidence rate of adverse reactions
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.